Armata Pharmaceuticals Inc. (ARMP)
ARMP trades on NYSE in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.10
-14.60% on the day
Market cap
$115.3M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ARMP on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000921114 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | WA |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-12-01 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report FORM 8-K | 8-K | 2026-09-23 |
| Latest proxy | DEF 14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TNYA | Tenaya Therapeutics Inc. | $0.5210 | -7.87% | $116.8M |
| ENGN | enGene Therapeutics Inc. | $1.63 | -4.12% | $109.2M |
| LENZ | LENZ Therapeutics Inc. | $3.40 | -5.82% | $106.8M |
| ABOS | Acumen Pharmaceuticals Inc. | $1.81 | -10.15% | $131.3M |
| VYGR | Voyager Therapeutics Inc. | $2.15 | -5.29% | $132.5M |
| HUMA | Humacyte Inc. | $0.3589 | -7.88% | $99.7M |
| AVXL | Anavex Life Sciences Corp. | $1.48 | -1.99% | $137.2M |
| OTLK | Outlook Therapeutics Inc. | $0.5638 | -3.64% | $137.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier